Corrigendum to: Post-treatment neutrophil to lymphocyte ratio as a prognostic tool in patients treated with tocilizumab for severe COVID-19 pneumonia - a single center experience

Marija Gomerčić Palčić; Marija Gomerčić Palčić; Marija Gomerčić Palčić; Hana Matijaca; Ivan Kruljac; Lucija Vusić; Vedran Hostić; Luka Vrbanić; Fanika Mrsić; Radovan Zrilić; Ivana Ćelap; Petar Gaćina; Petar Gaćina

doi:10.11613/BM.2023.031201

Gomerčić Palčić, Matijaca, Kruljac, Vusić, Hostić, Vrbanić, Mrsić, Zrilić, Ćelap, and Gaćina: Corrigendum to: Post-treatment neutrophil to lymphocyte ratio as a prognostic tool in patients treated with tocilizumab for severe COVID-19 pneumonia - a single center experience

Journal Information

Journal ID (publisher-id): BM

Journal ID (nlm-ta): Biochem Med (Zagreb)

Title: Biochemia Medica

Abbreviated Title: Biochem. Med. (Zagreb)

ISSN (print): 1330-0962

ISSN (electronic): 1846-7482

Publisher: Croatian Society of Medical Biochemistry and Laboratory Medicine

Article Information

Copyright statement: ©Croatian Society of Medical Biochemistry and Laboratory Medicine.

Copyright: 2023, Croatian Society of Medical Biochemistry

License (open-access):

This is an Open Access article distributed under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Publication date (print and electronic): 15 October 2023

Volume: 33

Issue: 3

Electronic Location Identifier: 031201

Corrigendum to: Post-treatment neutrophil to lymphocyte ratio as a prognostic tool in patients treated with tocilizumab for severe COVID-19 pneumonia - a single center experience

Marija Gomerčić Palčić[*][¹][²] ,Hana Matijaca[³] ,Ivan Kruljac[⁴] ,Lucija Vusić ,Vedran Hostić[⁵] ,Luka Vrbanić[²] ,Fanika Mrsić[⁶] ,Radovan Zrilić[⁷] ,Ivana Ćelap[⁸] ,Petar Gaćina[³][⁹]

Show more about author

Marija Gomerčić Palčić[*][¹][²]

Hana Matijaca[³]

Ivan Kruljac[⁴]

Lucija Vusić

Vedran Hostić[⁵]

Luka Vrbanić[²]

Fanika Mrsić[⁶]

Radovan Zrilić[⁷]

Ivana Ćelap[⁸]

Petar Gaćina[³][⁹]

[1] School of Medicine, University of Zagreb, Zagreb, Croatia

[2] Department of Internal Medicine, Sestre milosrdnice University Hospital Center, Division of Pulmonology, Zagreb, Croatia

[3] Department of Internal Medicine, Sestre milosrdnice University Hospital Center, Division of Hematology, Zagreb, Croatia

[4] Solmed Group, Department: Poliklinika Solmed, Zagreb, Croatia

[5] Department of Anesthesiology, Intensive Care Medicine and Pain Management, Sestre milosrdnice University Hospital Center, Zagreb, Croatia

[6] Department of Internal Medicine, Sestre milosrdnice University Hospital Center, Division of Clinical Immunology and Rheumatology, Zagreb, Croatia

[7] Polyclinic for Respiratory Diseases, Dom zdravlja Zagreb - Zapad, Zagreb, Croatia

[8] Department of Clinical Chemistry, Sestre milosrdnice University Hospital Center, Croatia

[9] School of Dental Medicine, University of Zagreb, Zagreb, Croatia

Author notes:

[*] Corresponding author: marijagomercic@yahoo.com

This is a correction of Biochem Med (Zagreb) 2023;33(2):020704. DOI: https://doi.org/10.11613/BM.2023.020704

Since the publication of the article, the authors have noticed that their first names and surnames in the by-line were listed in reverse. The correct by-line is presented above. We apologize to the authors for any inconvenience caused to the readers.

Journal Information

Article Information

Corrigendum to: Post-treatment neutrophil to lymphocyte ratio as a prognostic tool in patients treated with tocilizumab for severe COVID-19 pneumonia - a single center experience

OUTLINE

ARTICLE INFORMATION

ARTICLE METRICS

CITED BY Loading...

HOW TO CITE

SHARE ARTICLE

Useful links